Inicio > Oncología > Tratamiento con interferón alfa-2B recombinante en el carcinoma basocelular > Página 6

Tratamiento con interferón alfa-2B recombinante en el carcinoma basocelular

  • Sordo C, Gutiérrez C. Cáncer de piel y radiación solar: Experiencia peruana en la prevención y detección temprana del cáncer de piel y melanoma. Rev Peru Med Exp Salud Publica. 2013;30:113-7.
  • Hackett CB, Langtry JA. Basal cell carcinoma of the ala nasi arising in a port wine stain treated using mohs micrographic surgery and local flap reconstruction. Dermatol Surg. [Letter]. 2014 Ene 23.
  • Yan H, Wang S, Yu H, Zhu J, Chen C. Molecular pathways and functional analysis of mirna expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells. Pharmacology. [Research Support, Non-U.S. Gov’t]. 2013;92(3-4):167-74.
  • Wu S, Han J, Li WQ, Li T, Qureshi AA. Basal-cell carcinoma incidence and associated risk factors in u.S. Women and men. Am J Epidemiol. [Research Support, N.I.H., Extramural]. 2013 Sep 15;178(6):890-7.
  • Martínez Vera E, Rivas M, Arrúa Caballero M, Cardozo Cabral S. Tumor de párpados: 241 casos: Hallazgos y desafíos para la reconstrucción. Cirugía Plástica Ibero-Latinoamericana. 2013;39:145-52.
  • Peres LP, Fiorentin JZ, Baptista TdS, Fuzina DG, Blanco LFdO. Clinical and histopathological profile of basal cell carcinoma in a population from criciúma, santa catarina, brazil. An Bras Dermatol. 2012;87:657-9.
  • Arias Soto JC, Santos Silva D, García Gali MdJ, Ortiz Silveira M, Matienzo Vergara SdlC. Caracterización clinicoepidemiológica de pacientes con tumores palpebrales malignos. MEDISAN. 2012;16:1870-6.
  • World Health Organization. How common is skin cancer? [Internet]: 2010 [citado 2014 Ene 10]; Disponible en:

http://www.who.int/uv/faq/skincancer/en/index1.html

  • Zemelman V, Ramírez C, Alvo A, Aedo A, Feldman M. Carcinoma espinocelular en hospitales públicos de la región metropolitana de chile: Análisis de la localización anatómica, género y edad. 2010.
  • Sordo C, Gutierrez C. Skin cancer and sun radiation: Peruvian experience in the prevention and early detection of skin cancer and melanoma. Rev Peru Med Exp Salud Publica. 2013 Mar;30(1):113-7.
  • D’Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. Uv radiation and the skin. Int J Mol Sci. 2013;14(6):12222-48.
  • Council ML. Common skin cancers in older adults: Approach to diagnosis and management. Clin Geriatr Med. [Review]. 2013 May;29(2):361-72.
  • Manzur J. Díaz J, Cortés M. Dermatología. La Habana,Edic.Ciencias Médicas; 2002. 277-9.
  • México. Secretaría de Salud. Dirección General de Epidemiología. Compendio del Registro Nacional Histopatológico de Neoplasias Malignas. México D.F: Secretaría de Salud; 2009.
  • McCalmont TH. The shape of basal cell carcinoma. J Cutan Pathol. [Editorial]. 2014 Mar;41(3):283-5.
  • Tsai MR, Cheng YH, Chen JS, Sheen YS, Liao YH, Sun CK. Differential diagnosis of nonmelanoma pigmented skin lesions based on harmonic generation microscopy. J Biomed Opt. 2014 Mar 1;19(3):36001.
  • Robati RM, Toossi P, Karimi M, Ayatollahi A, Esmaeli M. Screening for skin cancer: A pilot study in tehran, iran. Indian J Dermatol. 2014 Ene;59(1):105.
  • Mansfield AS, Rabe KG, Slager SL, Schwager SM, Call TG, Brewer JD, et al. Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia. J Oncol Pract. 2014 Ene 1;10(1):e1-4.
  • Cancer in australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012. Asia Pac J Clin Oncol. 2013 Sep;9(3):199-213.
  • Streeton CL, Gospodarevskaya E, Harris A. Treatment of basal cell carcinomas by general practitioners in australia. Int J Dermatol. 2006 Abr;45(4):345-51.
  • Malhotra R, Huilgol SC, Huynh NT, Selva D. The australian mohs database, part i: Periocular basal cell carcinoma experience over 7 years. Ophthalmology. 2004;111(4):624-30.
  • Custódio G, Locks LH, Coan MF, Gonçalves CO, Trevisol DJ, Trevisol FS. Epidemiologia dos carcinomas basocelulares em tubarão, Santa Catarina (sc), Brasil, entre 1999 e 2008. An Bras Dermatol. 2010;85:819-26.
  • Ruiz Lascano A, Kuznitzky R, Garay I, Ducasse C, Albertini R. Factores de riesgo para carcinoma basocelular: Estudio de casos-controles en córdoba. Medicina (Buenos Aires). 2005;65:495-500.
  • Quinn A.G. Perkins W. Non-Melanoma Skin Cancer and Other Epidermal Skin Tumours. En Roock´s Textbook of Dermatology, 8va edition. Blackwell Publishing Ltd ;2010. P. 2630- 35.
  • Dirección Nacional de Registros Médicos y Estadísticas de Salud. Incidencia de cáncer según sexo y principales localizaciones. Anuario Estadístico de Salud. La Habana: Ecimed; 2012.
  • Victoria Bárzaga HO. Caracterización clínica e histopatológica del cáncer cutáneo no melanoma. Revista Archivo Médico de Camagüey. 2010;14:0-.
  • Caroe TK, Ebbehoj NE, Wulf HC, Agner T. Occupational skin cancer may be underreported. Dan Med J. 2013 May;60(5):A4624.
  • Jeon HM, Kim do H, Jung WH, Koo JS. Expression of cell metabolism-related genes in different molecular subtypes of triple-negative breast cancer. Tumori. [Research Support, Non-U.S. Gov’t]. 2013 Jul-Ago;99(4):555-64.
  • Lahtz C, Kim SI, Bates SE, Li AX, Wu X, Pfeifer GP. Uvb irradiation does not directly induce detectable changes of DNA methylation in human keratinocytes. F1000Res. 2013;2:45.
  • Li C, Srivastava RK, Elmets CA, Afaq F, Athar M. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of yap, a hippo signaling-related protein. Biochem Biophys Res Commun. [Research Support, N.I.H., Extramural]. 2013 Sep 6;438(4):607-12.
  • Makhzoumi ZH, Arron ST. Photosensitizing agents and the risk of non-melanoma skin cancer: A population-based case-control study. J Invest Dermatol. [Comment]. 2013 Ago;133(8):1922-3.
  • Di Lernia V, Ricci C, Zalaudek I, Argenziano G. Metastasizing basal cell carcinoma. Cutis. 2013 Nov;92(5):244-6.
  • Kurian RR, Di Palma S, Barrett AW. Basal cell carcinoma metastatic to parotid gland. Head Neck Pathol. 2013 Nov 15.
  • McCusker M, Basset-Seguin N, Dummer R, Lewis K, Schadendorf D, Sekulic A, et al. Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease. Eur J Cancer. [Review]. 2014 Mar;50(4):774-83.
  • Ismail A, Yusuf N. Type i interferons: Key players in normal skin and select cutaneous malignancies. Dermatol Res Pract. [Review]. 2014;2014:847545.
  • Wettstein R, Erba P, Itin P, Schaefer DJ, Kalbermatten DF. Treatment of basal cell carcinoma with surgical excision and perilesional interferon-alpha. J Plast Reconstr Aesthet Surg. 2013 Jul;66(7):912-6.
  • Rotondi M,
Páginas: 1 2 3 4 5 6 7 8